Plavix Deal Triggers More Antitrust Charges
Marking the latest swipe in the epic battle over blockbuster blood thinner Plavix, Apotex Corp., Bristol-Myers Squibb Co. and French pharmaceutical giant Sanofi-Aventis have been hit with antitrust charges by a...To view the full article, register now.
Already a subscriber? Click here to view full article